PepGen Inc. (PEPG)
NASDAQ: PEPG
· Real-Time Price · USD
5.88
3.22 (121.05%)
At close: Sep 25, 2025, 3:59 PM
5.68
-3.40%
After-hours: Sep 25, 2025, 05:20 PM EDT
121.05% (1D)
Bid | 5.5 |
Market Cap | 192.86M |
Revenue (ttm) | 1.49M |
Net Income (ttm) | -96.92M |
EPS (ttm) | -2.96 |
PE Ratio (ttm) | -1.99 |
Forward PE | -1.11 |
Analyst | Buy |
Dividends | n/a |
Ask | 5.54 |
Volume | 123,785,612 |
Avg. Volume (20D) | 786,746 |
Open | 5.88 |
Previous Close | 2.66 |
Day's Range | 4.90 - 6.34 |
52-Week Range | 0.88 - 9.94 |
Beta | 1.17 |
Ex-Dividend Date | n/a |
About PEPG
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PEPG
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PEPG stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 hours ago
PepGen shares are trading higher. The company anno...
Unlock content with
Pro Subscription
1 day ago
+36.41%
PepGen shares are trading higher after the company announced clinical data today from the 15 mg/kg dose cohort of its ongoing FREEDOM-DM1 Phase 1 single ascending dose study in patients with myotonic dystrophy type 1.